Clearer insights into IgE glycosylation will enhance understanding and treatment of allergy and IgE-mediated atopic diseases and will help inform the development of novel antibody scaffolds aimed at filling the gaps in existing monoclonal antibodies for cancer therapy. The gene discussed is IGHE; the disease is Allergy.